Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR-Based Assay for Point-of-Care Pharmacogenetic CYP2C19 Genotyping.

ACS sensors·2026
Same author

PRDX1 as a novel urinary biomarker for bladder cancer: Development of an integrated fiber optic sensing platform.

Talanta·2026
Same author

Case Report: Retrospective surgeon-guided reassessment of clinical target volume delineation in low-dose radiotherapy for postoperative chylothorax: an eight-patient case series.

Frontiers in medicine·2026
Same author

Comprehensive Profiling of Human Urinary Mercapturic Acid Conjugates Associated with Exposure to Reactive Chemical Species Using Enzymatic Deacetylation and High-Resolution Mass Spectrometry.

Analytical chemistry·2026
Same author

Enhanced Environmental PFAS Characterization Using a Virtual High-Resolution Mass Spectral Library Generated by Transfer Learning-Based Neural Network.

Environmental science & technology·2026
Same author

Survival benefits of neoadjuvant chemotherapy in advanced pancreatic cancer with vascular resection: who benefits the most? A study on key predictive factors.

Updates in surgery·2026

Related Experiment Video

Updated: Sep 20, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.5K

Macrophage activation determines muscle wasting in pancreatic cancer.

Chia-Jung Chang1, Po-Hsien Huang2,3, Szu-Ying Chen4

  • 1Department of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan.

Oncogene
|May 29, 2025
PubMed
Summary
This summary is machine-generated.

Cachexia onset in tumor-bearing mice is linked to specific macrophage signals, particularly CHI3L1. Targeting this pathway with an anti-CHI3L1 antibody reduced muscle wasting, tumor growth, and metastasis.

More Related Videos

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

25.5K
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.3K

Related Experiment Videos

Last Updated: Sep 20, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

16.5K
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

25.5K
In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.3K

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The contribution of non-cancerous cells in the tumoral microenvironment to cachexia remains poorly understood.
  • The precise timing and cellular origins of cachexia onset are unpredictable, despite advances in cancer cachexia research.

Purpose of the Study:

  • To investigate the role of non-cancerous cells in the tumoral microenvironment in driving cachexia.
  • To identify specific cell types and molecular signals responsible for early-onset muscle wasting in a pancreatic cancer model.
  • To elucidate the CHI3L1-HDAC3 signaling axis in cachexia progression.

Main Methods:

  • Utilized a transgenic KrasLSL-G12D/+;Trp53flox/flox;Pdx1-Cre (KP2C) GEMM for pancreatic cancer.
  • Performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells (PBMCs) and mouse-derived syngeneic transplants (MDSTs).
  • Investigated the effects of CHI3L1 on C2C12 myoblasts and utilized skeletal muscle-specific conditional Hdac3 knockout mice.

Main Results:

  • scRNA-seq identified CHI3L1 and CHI3L3 as differentially expressed genes, with macrophages mediating early muscle wasting.
  • Recombinant CHI3L1 suppressed myotube formation and upregulated specific inflammatory and signaling genes in myoblasts.
  • Targeting CHI3L1-HDAC3 signaling via Hdac3 knockout or anti-CHI3L1 antibody treatment reduced muscle wasting, tumor growth, and metastasis.

Conclusions:

  • Pancreatic tumor-associated macrophages play a significant role in mediating skeletal muscle wasting.
  • The CHI3L1-HDAC3 signaling pathway is a key mechanism driving cachexia progression.
  • Targeting CHI3L1 offers a potential therapeutic strategy to combat cancer cachexia and associated tumor progression.